CEACAM5 and colorectal carcinoma: Furthermore, anti-Fn-IgA exhibited much higher sensitivity (27.27%) than CEA (9.09%) or a combination of CEA and CA19-9 (16.36%) for early CRC detection without compromising specificity (96.21%).